BAUSCH HEALTH COMPANIES Stock (BHC.re) Price Chart, Analysis, and Forecast

View the real-time BAUSCH HEALTH COMPANIES (BHC.re) stock quote and decide if you want to buy and when to sell. Find predictions, financials, the latest news and other information to help you with your stock investing.

Buy
Sell
Daily price range:
Trade [object Object]

All investing involves risk

live price

Live Chart

Past performance is not a reliable indicator of future results.

Is BAUSCH HEALTH COMPANIES a good stock to buy?

The quantitative stock rating system created by TipRanks shows that BAUSCH HEALTH COMPANIES price is neutral. Its Smart Score¹ of 6 indicates BAUSCH HEALTH COMPANIES is a top stock to add to your watchlist.

6

Smart Score

Why is BAUSCH HEALTH COMPANIES stock price going up?

BAUSCH HEALTH COMPANIES

Bulls say

  • Company guidance

    Company guidance exceeded prior analyst estimates, implying management expects stronger top-line growth than the market had anticipated.

  • Pipeline opportunity — larsucosterol

    Investor focus on larsucosterol as a potential first approved treatment for severe alcohol-associated hepatitis could create a meaningful new commercial opportunity if regulatory approval is achieved.

  • Revenue and product mix

    Total revenue surpassed analysts' expectations driven by stronger vision-care sales, indicating diversification of revenue sources beyond core pharmaceuticals.

Why is BAUSCH HEALTH COMPANIES stock price going down?

BAUSCH HEALTH COMPANIES

Bears say

  • Clinical trial setback

    Phase three RED-C program failing to meet its primary endpoint undermines prospects for the rifaximin asset and reduces expected contribution from new formulations.

  • Loss of exclusivity risk

    Loss of exclusivity for Xifaxan represents a major revenue overhang that could materially reduce future sales without an immediate replacement product.

  • Profitability and deal-making constraints

    Higher selling and administrative expenses together with elevated interest costs and limited capital flexibility constrain the company's ability to pursue large business development deals and put pressure on profitability.

What is happening with
BAUSCH HEALTH COMPANIES stock price today?

  • The price of BAUSCH HEALTH COMPANIES today, as of , was $. That's down % from the previous session's BAUSCH HEALTH COMPANIES closing price.

  • The BAUSCH HEALTH COMPANIES price is declining this week. Compared to last week, the rate of BAUSCH HEALTH COMPANIES is down --, and it's down -- from one month ago.

  • The 52-week BAUSCH HEALTH COMPANIES price high is $, while the 52-week BAUSCH HEALTH COMPANIES price low is $.

  • Year to date, BAUSCH HEALTH COMPANIES price is down -- from the beginning of the year and has had a return of -- in the last 12 months.

What is the sentiment of BAUSCH HEALTH COMPANIES stock in يونيو 2026?

The sentiment score², indicating how the crowd feels about BAUSCH HEALTH COMPANIES stock is NEGATIVE. The sentiment signal³ observed at the start of the market session, offering insights into whether BAUSCH HEALTH COMPANIES stock price today is likely to increase, decrease, or remain steady, is BEARISH.

News Sentiment
Neutral
Neutral
Bullish: --Bearish: --
Blogger Opinion
Bullish
Bullish
Bullish: 100%Bearish: 0%
Investors Sentiment
Neutral
Neutral
Past 7d: 1%Past 30d: -1%

Table with the sentiment of BAUSCH HEALTH COMPANIES stock in يونيو 2026

BAUSCH HEALTH COMPANIES stock analysis

Based on analysts giving ratings to BAUSCH HEALTH COMPANIES stock, the consensus⁴ is HOLD. Hedge funds activity⁵ increased in the last quarter, while Insider activity⁶ trend is N/A (N/A BAUSCH HEALTH COMPANIES shares)

BAUSCH HEALTH COMPANIES Technical Analysis

Trending downNegative
SMA
Trending down-0.16
Momentum

Simple moving average: 20/200 days

Momentum: 12 month change

BAUSCH HEALTH COMPANIES Insider Activity

No data available

BAUSCH HEALTH COMPANIES Fundamentals

Trending up+121.0%
Return on equity
Trending down-7.0%
Asset Growth

Return on equity: last 12 months

Asset growth: 12 month change

Discover key BAUSCH HEALTH COMPANIES stock trends with NAGA Insights

What am I Missing?

  • Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.

  • Access advanced BAUSCH HEALTH COMPANIES charting, technical analysis, and live market data from TradingView.

  • Get AI-powered BAUSCH HEALTH COMPANIES trade signals, in-depth market analysis, and technical strategy insights from Trading Central.

Sign up

All investing involves risk

Best Stocks Discover

BAUSCH HEALTH COMPANIES stock outlook 2026

Analysts forecast BAUSCH HEALTH COMPANIES stock price will rise/fall in the next 12 months. Based on 5 Wall Street analysts offering BAUSCH HEALTH COMPANIES price predictions in the last 3 months, the average price target is $7.67.

The highest BAUSCH HEALTH COMPANIES stock forecast is $9.00, while the lowest is $7.00. The average BAUSCH HEALTH COMPANIES price target represents a 54.64% change from the actual price of $.

BAUSCH HEALTH COMPANIES stock price prediction⁷

  • Highest price target$9.00
  • Average price target$7.67
  • Lowest price target$7.00

BAUSCH HEALTH COMPANIES stock forecast⁸

  • Buy0.00%
  • Hold100.00%
  • Sell0.00%

Overview of stock forecast and price predictions 2026. Analyst price targets and consensus are estimates only and do not constitute guarantees of future outcomes.

Investing in BAUSCH HEALTH COMPANIES stock

There are two ways to invest in BAUSCH HEALTH COMPANIES stock: trading BAUSCH HEALTH COMPANIES stock through derivatives like CFDs or buying shares of BAUSCH HEALTH COMPANIES stock outright. With NAGA.com, you can do both and more.


Buy BAUSCH HEALTH COMPANIES shares of stock if you want to hold them for a long time. You commit the full value of the BAUSCH HEALTH COMPANIES shares outright and profit only if they increase in price.


Trade BAUSCH HEALTH COMPANIES if you want more flexibility — say you want to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think BAUSCH HEALTH COMPANIES stock’s price will rise, or you can open a sell position (go short) if you believe the BAUSCH HEALTH COMPANIES stock’s price will fall.


You won’t need to commit to the full value of the position. But bear in mind that leverage can increase both your profits and losses.

How to invest

How to trade BAUSCH HEALTH COMPANIES with CFDs?

  • If you want to speculate on BAUSCH HEALTH COMPANIES price, search for BAUSCH HEALTH COMPANIES CFD. Then click on the "BAUSCH HEALTH COMPANIES" symbol to view the chart and other insights before placing your trade. Also, review "BAUSCH HEALTH COMPANIES" contract specification to be aware of all the BAUSCH HEALTH COMPANIES CFD trading conditions.

How to buy BAUSCH HEALTH COMPANIES stock?

  • If you want to buy BAUSCH HEALTH COMPANIES shares outright to hold them for a long time, search for BAUSCH HEALTH COMPANIES stock with ownership (Real Stocks). Then click on the "BAUSCH HEALTH COMPANIES" symbol to view the chart and other insights before placing your trade. Also, review "BAUSCH HEALTH COMPANIES" contract specification to be aware of all the BAUSCH HEALTH COMPANIES stock buying conditions.

trading conditions:

Platform
MT5
Ticker
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission
Monthly price change (%)0.00%
Annual price change (%)0.00%
Digits
Tick value
Trading Hours & Fees
Get Started

All investing involves risk

BAUSCH HEALTH COMPANIES company presentation

BHC

Bausch Health Companies

Real Stocks

--
--

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Latest BAUSCH HEALTH COMPANIES stock news

Discover the latest news that can influence BAUSCH HEALTH COMPANIES’s earnings sentiment and BAUSCH HEALTH COMPANIES forecast and price predictions.

Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)
03/06/2026/04:10
Read more
Neutral
Bausch Health Companies Inc at RBC Capital Markets Global Healthcare Conference Transcript
20/05/2026/16:01
Read more
Neutral
Bausch Health Companies Inc Annual Shareholders Meeting Transcript
19/05/2026/15:00
Read more

FAQs about BAUSCH HEALTH COMPANIES trading

The price of BAUSCH HEALTH COMPANIES stock today, as of , was . That's down % from the previous session's BAUSCH HEALTH COMPANIES closing price.

IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ ⁵ ⁶ The Smart Score is a proprietary quantitative stock scoring system created by TipRanks. It assigns stocks a score from one to ten, based on 8 market key factors. The lowest score is 1, and the highest is 10. Stocks with a score of 8, 9, or 10 are considered Outperform, and with a score of 1, 2, or 3 are considered Underperform. The score is data-driven and does not involve any human intervention. The contributing market factors are Wall Street analyst ratings, Corporate insider transactions, Financial blogger opinions, Individual investor sentiment, Hedge fund manager activity, News sentiment, Technicals and Fundamentals. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ⁴ ⁷ ⁸ TipRanks’ consensus ratings provide an aggregated view of expectations and consensus on a particular stock from a wide range of global analyst opinions. They’re then condensed into a single indicator, which can help you make investment decisions based on expert analysis. TipRanks’ 12-month forecast is a consensus price target derived from Wall Street analysts’ projections made over the past three months. It forecasts the potential high, low, and average share price for a stock one year from now, along with the average expected upside or downside percentage. ² ³ The sentiment signal and sentiment score are provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.

Need Help? Visit our Help Section
Download NAGA Trader

Copyright © 2026 – All rights reserved.

NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.

The website is operated by NAGA Capital Ltd which is authorised and regulated by the Financial Services Authority Seychelles (FSA) under licence No. SD026. The registered address of Suite 3, Jivan’s Complex, Global Village, Mont Fleuri, Mahe, Seychelles. Tel: +248 4373121

Other group entities: NAGA Markets Europe Ltd, authorised and regulated by the Cyprus Securities and Exchange Commission ("CySEC") under license No. 204/13 with registered address at Agias Zonis 11, Limassol, 3027, Cyprus and NAGA Global (CY) Ltd, with registered address at Nikokreontos 2, NICE DREAM, 6th floor, Flat/Office 601, 1066, Nicosia, Cyprus.

RISK WARNING: Derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how derivatives work and whether you can afford to take the high risk of losing your money. This is not investment advice. Trading with NAGA Trader by following and/or copying or replicating the trades of other traders involves high levels of risks, even when following and/or copying or replicating the Lead Traders. Such risks include the risk that you may be following/copying the trading decisions of possibly inexperienced/unprofessional traders, or traders whose ultimate purpose or intention, or financial status may differ from yours. Before making an investment decision, you should rely on your own assessment of the person making the trading decisions and the terms of all the legal documentation.

Restricted countries: NAGA Capital Ltd does not provide services for the residents of certain countries, such as Afghanistan, Albania, American Samoa, Anguilla, Australia, Austria, Barbados, Belarus, Belgium, Bermuda, British Indian Ocean Territory, Bulgaria, Burkina Faso, Canada, Cayman Islands, Central African Republic, Christmas Island, Cocos (Keeling) Islands, The Democratic Republic of the Congo, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Falkland Islands (Malvinas), Finland, France, Germany, Gibraltar, Greece, Guam, Haiti, Heard Island and McDonald Islands, Hungary, Iceland, Islamic Republic of Iran, Ireland, Isle of Man, Israel, Italy, Jamaica, Japan, Jersey, Democratic People's Republic of Korea, Latvia, Libyan Arab Jamahiriya, Liechtenstein, Lithuania, Luxembourg, Mali, Malta, Montserrat, Mozambique, Myanmar, Netherlands, New Zealand, Norfolk Island, Norway, Palestinian Territory, Occupied, Pitcairn, Poland, Portugal, Romania, Saint Helena, Ascension and Tristan Da Cunha, San Marino, Senegal, Serbia, Slovakia, Slovenia, Somalia, South Georgia and the South Sandwich Islands, South Sudan, Spain, Sri Lanka, Sweden, Switzerland, Syrian Arab Republic, Trinidad and Tobago, Tunisia, Turks and Caicos Islands, Uganda, United Kingdom and any other countries where the citizens have British proof of identity (i.e. British Virgin Island, Gibraltar, Isle of Man etc.), United States, U.S. Minor Islands, Vanuatu, Virgin Islands, British, Virgin Islands, U.S., Yemen, and Zimbabwe.